Max Robotics — Global Service Robot Directory + US Certification

About

Hongqing Xi is a surgical oncologist whose research focuses on the surgical management of gastric cancer, with particular emphasis on minimally invasive techniques and function-preserving approaches. His work sits at the intersection of oncological outcomes, surgical innovation, and patient quality of life, making meaningful contributions to the evolving field of robotic and laparoscopic gastrectomy. Xi's most recognized contribution examines robot-assisted versus laparoscopy-assisted proximal gastrectomy for early gastric cancer in the upper stomach, a study that has garnered 16 citations and provides critical comparative data on oncological outcomes, surgical stress, and nutritional status following these procedures. His subsequent multi-institutional randomized clinical trial protocol, comparing totally laparoscopic and totally robotic distal gastrectomy across clinical stages I–III, reflects his commitment to rigorous evidence generation in a field where the Da Vinci robotic platform is rapidly expanding. Collectively, Xi's research addresses a timely clinical challenge: as early gastric cancer detection improves, surgeons must balance curative intent with functional preservation and recovery. His work helps guide surgical decision-making for thousands of patients annually and positions him as a credible voice in advancing minimally invasive gastric surgery standards internationally.